Developing prediction models for symptom severity around the time of discharge from a tertiary-care program for treatment-resistant psychosis

Antipsychotics are the only therapeutic class indicated in the symptomatic management of psychotic disorders. However, individuals diagnosed with schizophrenia or schizoaffective disorder may not always benefit from these first-line agents. This refractoriness to conventional treatment can be diffic...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Lik Hang N., Procyshyn, Ric M., White, Randall F., Gicas, Kristina M., Honer, William G., Barr, Alasdair M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282838/
https://www.ncbi.nlm.nih.gov/pubmed/37350999
http://dx.doi.org/10.3389/fpsyt.2023.1181740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282838/
https://www.ncbi.nlm.nih.gov/pubmed/37350999
http://dx.doi.org/10.3389/fpsyt.2023.1181740

Ejemplares similares